News

GoodCap Pharmaceuticals Announces Publication of International Patent Application

Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap"), a biopharmaceutical company developing low-dose psychedelic therapies, is…

2 years ago

Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…

2 years ago

Melzi Surgical to Participate at the Society of Robotic Surgery 2022 Annual Meeting

Company to showcase the Melzi Sharps Finder, a U.S. FDA registered device designed to locate lost needles and objects for…

2 years ago

9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome

Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel SyndromeRALEIGH, NC / ACCESSWIRE…

2 years ago

Enlighta Announces Appointment of John F. Wallace and Dr. Christina Gong as Independent Directors

TORTOLA, BVI / ACCESSWIRE / June 30, 2022 / Enlighta Inc. (TSXV:NLTA) ("Enlighta" or the "Company") is pleased to announce…

2 years ago

Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products

Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A EventSOUTH EASTON, MA / ACCESSWIRE / June 30, 2022…

2 years ago

SphingoTec Appoints Jörg Menten as CEO to Accelerate Commercialization and Global Growth

SphingoTec appoints Jörg Menten as Chief Executive Officer (CEO) as from July 1, 2022 to drive the commercialization and scale…

2 years ago

9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome

Phase 2 VIBRANT study identifies a dose and dosing interval with >25% improvement in the primary endpoint of 24-hour mean…

2 years ago

Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis

Lung Cancer Orchestrator June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess…

2 years ago

CISOs Connect Names NRC Health Chief Security and Privacy Officer Among 2022 Top 100 CISOs in the Country

Cris Ewell recognized by second-annual C100 awards for outstanding achievements in the cybersecurity communityLINCOLN, Neb., June 30, 2022 (GLOBE NEWSWIRE)…

2 years ago